Analysis of Epigenetic Regulation in Tumors
Epigenetic modifications, defined as heritable changes in gene expression that occur without alterations to the underlying DNA sequence, have emerged as a pivotal driving force in the oncogenic process. At Alfa Cytology, we delve deep into the intricate world of cancer research, focusing on the crucial role of epigenetic regulation in tumor development and progression.
Introduction to Epigenetic Regulation
Epigenetic regulation refers to modifications in gene expression that are not caused by changes in the DNA sequence but rather by alterations in DNA methylation, histone modifications, and non-coding RNA expression. Epigenetic modifications can have a profound impact on gene expression patterns and cellular behavior. Aberrant epigenetic regulation has been implicated in cancer development and progression, with alterations in DNA methylation and histone modifications being commonly observed in various types of cancer. These changes can lead to abnormal gene expression, silencing of tumor suppressor genes, and activation of oncogenes.
Fig.1 Aberrant epigenetic alterations in tumour development. (Lu, Y., et al., 2020)
Our Services
At Alfa Cytology, our dedicated team of biological experts provides comprehensive services to unravel the intricate epigenetic landscape of cancer.
Our team of expert scientists specializes in dissecting the complex interplay between genetic and epigenetic alterations, leveraging advanced bioinformatics tools to identify key epigenetic drivers and their downstream effectors. Our services include, but are not limited to:
DNA Methylation Analysis
Our state-of-the-art techniques, including bisulfite sequencing and methylation-specific PCR, allow us to map the methylation patterns across the genome, identifying key epigenetic signatures associated with cancer.
Histone Modification Profiling
We utilize cutting-edge techniques, such as chromatin immunoprecipitation (ChIP) and mass spectrometry, to quantify and characterize the various histone modifications that govern the transcriptional landscape of tumors.
Chromatin Accessibility Mapping
By employing techniques like ATAC-seq and DNase-seq, we can map the open and accessible regions of the chromatin, providing insights into the dynamic regulatory elements that influence gene expression in cancer cells.
Epigenetic Biomarker Discovery
Our bioinformatics and data analysis capabilities enable us to identify novel epigenetic biomarkers that can serve as valuable tools for early detection, disease monitoring, and predictive modeling of cancer.
For a more integrated and comprehensive approach to your cancer research, we invite you to explore our epigenomics services. These specialized services offer a holistic view of epigenetic changes across the entire genome, providing you with a robust and detailed perspective on the intricate interplay of epigenetic factors in cancer biology.
Our Advantages
- We offer customized solutions tailored to your specific needs. Whether you require genome-wide analysis, targeted profiling of specific regions of interest, or integrative multi-omics approaches, our team will work closely with you to design a comprehensive analysis strategy that best suits your research goals.
- Our bioinformatics team excels in data interpretation and analysis, providing you with meaningful insights and actionable results. We utilize algorithms and statistical methods to identify key epigenetic features, define regulatory networks, and uncover novel associations between epigenetic alterations and clinical outcomes.
At Alfa Cytology, our multidisciplinary team of epigenetics experts is at the forefront of unraveling the complex interplay between epigenetic dysregulation and cancer progression. By leveraging our extensive expertise and state-of-the-art analytical platforms, we are poised to make groundbreaking contributions to the development of novel, epigenetically-targeted cancer therapies. If you are interested in our service, please contact us for more details.
Reference
- Lu, Y., et al.; (2020). Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy. Molecular cancer, 19, 1-16.
For research use only.
Related Services
